Daehan New Pharm Co. Ltd Capital Reinvestment Ratio
Daehan New Pharm Co. Ltd capital reinvestment ratio. Daehan New Pharm Co. Ltd (054670) has a Capital Reinvestment Ratio of 2.61x as of September 2025, meaning it reinvests 3% of its operating cash flow (₩4.43 Billion) in capital expenditures (₩11.53 Billion). Check how aggressively does Daehan New Pharm Co. Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Daehan New Pharm Co. Ltd (2011–2024)
Capital reinvestment ratio of Daehan New Pharm Co. Ltd from 2011 to 2024. This chart tracks Daehan New Pharm Co. Ltd's Capital Reinvestment Ratio across 12 annual periods. Also explore Daehan New Pharm Co. Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Daehan New Pharm Co. Ltd Capital Reinvestment Ratio by Year (2011–2024)
Daehan New Pharm Co. Ltd capital reinvestment ratio by year from 2011 to 2024. For the full cash flow conversion analysis, see 054670 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.81x | ₩18.95 Billion | ₩34.26 Billion | ▲ +128.8% |
| 2023 | 0.79x | ₩12.57 Billion | ₩9.93 Billion | ▲ +220.5% |
| 2022 | 0.25x | ₩14.25 Billion | ₩3.51 Billion | ▼ -61.3% |
| 2021 | 0.64x | ₩16.58 Billion | ₩10.55 Billion | ▼ -8.9% |
| 2020 | 0.70x | ₩13.55 Billion | ₩9.46 Billion | ▲ +76.2% |
| 2019 | 0.40x | ₩22.89 Billion | ₩9.08 Billion | ▲ +368.9% |
| 2018 | 0.08x | ₩20.47 Billion | ₩1.73 Billion | ▼ -83.8% |
| 2016 | 0.52x | ₩8.75 Billion | ₩4.57 Billion | ▲ +5.5% |
| 2015 | 0.50x | ₩7.80 Billion | ₩3.86 Billion | ▼ -25.9% |
| 2014 | 0.67x | ₩10.02 Billion | ₩6.69 Billion | ▼ -86.2% |
| 2012 | 4.83x | ₩256.82 Million | ₩1.24 Billion | ▲ +1269.7% |
| 2011 | 0.35x | ₩3.42 Billion | ₩1.20 Billion | — |